Order results by:
| Issue | Title | |
| Vol 7, No 4 (2014) | APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES | Abstract similar documents |
| V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova | ||
| "... financing of rare disease drugs remains a serious problem for both foreign countries and our ..." | ||
| Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract similar documents |
| D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
| "... of drugs for the treatment of rare (orphan) diseases. Material and methods. Analysis of pharmaceutical ..." | ||
| Vol 10, No 1 (2017) | RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION | Abstract similar documents |
| M. V. Sura | ||
| "... of medicines to treat rare diseases, in accordance with the list of rare (orphan) diseases, the list ..." | ||
| Vol 18, No 2 (2025) | Data analysis of medicines aimed at health technology assessment within the activities of the “Circle of Kindness” Foundation from 2021 to 2024 | Abstract similar documents |
| V. V. Omelyanovskiy, A. A. Kingshott, T. S. Teptsova, P. A. Mukhortova, A. G. Kharitonova, S. I. Zinadinov, L. O. Krekhtunova, N. A. Aldushchenko, A. А. Kozak, V. A. Ryagina | ||
| "... additional financial support for children with severe life-threatening and chronic diseases (including rare ..." | ||
| Vol 13, No 3 (2020) | The review of the foreign experience on the financing of innovative medical technologies | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev | ||
| "... The article presents a review of the foreign approaches to the mechanisms of financing of medical ..." | ||
| Vol 8, No 2 (2015) | REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS | Abstract similar documents |
| Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev | ||
| "... Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal ..." | ||
| Vol 7, No 4 (2014) | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY | Abstract similar documents |
| D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
| "... the article presents the results of analysis of the state procurement of the drugs for rare ..." | ||
| Vol 11, No 4 (2018) | Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease | Abstract similar documents |
| V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev | ||
| "... Болезнь Фабри (БФ) – тяжелое орфанное прогрессирующее наследственное заболевание из группы ..." | ||
| Vol 14, No 4 (2021) | Development of the system of state financing of Compulsory Health Insurance | Abstract similar documents |
| А. V. Larionov, S. V. Russkikh, S. V. Maslennikov | ||
| "... Objective: to study the potential for the development of financing the Compulsory Health Insurance ..." | ||
| Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| "... обеспечение больных с редкими заболеваниями, включенными в перечень редких заболеваний (24 заболевания ..." | ||
| Vol 11, No 3 (2018) | Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies | Abstract similar documents |
| T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov | ||
| Vol 11, No 2 (2018) | Current practice of organizing and financing the departmental healthcare system for the military in developed countries: a review | Abstract similar documents |
| T. P. Bezdenezhnykh, D. V. Lukyantseva | ||
| "... discussions on whether its further support and financing is worthwhile. The Defense Ministry of the Russian ..." | ||
| Vol 17, No 4 (2024) | Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis | Abstract similar documents |
| J. A. Agafonova, V. V. Omelyanovskiy | ||
| Vol 14, No 3 (2021) | Review of methods for planning the scope of medical care and financing of the healthcare system by the subjects of the Russian Federation | Abstract similar documents |
| S. A. Kovaleva, D. V. Fedyaev, N. N. Sisigina | ||
| "... and financing of medical care in the subjects of the Russian Federation. The relevance of the issue is due ..." | ||
| Vol 5, No 3 (2012) | RATIONALE FOR THE SYSTEM OF INDICATORS, INTENDED FOR THE EVALUATION OF INVESTMENT EFFECTIVENESS IN THE FINANCING OF INVESTMENT PROJECTS IMPLEMENTED USING THE FUNDS OF THE POPULATION | Abstract similar documents |
| E. V. Litvinenko | ||
| Vol 9, No 4 (2016) | PROPOSALS AND RECOMMENDATIONS FOR OPTIMIZATION OF THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS | Abstract similar documents |
| D. V. Fedyaev, D. V. Lukyantseva, V. I. Ignatyeva | ||
| Vol 9, No 4 (2016) | REVIEW OF PRACTICE AND POSSIBLE DIRECTIONS OF CONCRETIZATION THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS | Abstract similar documents |
| D. V. Fedyaev, L. S. Melnikova, V. I. Ignatyeva | ||
| Vol 13, No 3 (2020) | The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation | Abstract similar documents |
| D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova | ||
| "... and financing of medical help based on the calculation for Program on State Guarantees to Deliver Free Medical ..." | ||
| Vol 13, No 4 (2020) | Development of a method for calculation of demand for medical personnel in the healthcare of the Russian Federation, using a mathematical model | Abstract similar documents |
| V. V. Omelyanovsky, T. V. Semenova, D. V. Lukyantseva, D. V. Fedyaev, E. A. Shalaeva | ||
| "... финансирования, в том числе направляемых на обеспечение, поддержание и развитие кадровых ресурсов здравоохранения. ..." | ||
| Vol 15, No 2 (2022) | Improving the efficiency of the medicine provision system for patients with malignant neoplasms | Abstract similar documents |
| Yu. A. Agafonova, D. V. Fedyaev, A. V. Snegovoy, V. V. Omelyanovskiy | ||
| "... the financing needs of the complete transfer of financial support of medical care in the field of oncology ..." | ||
| Vol 8, No 3 (2015) | RESEARCH EXCELLENCE INDEX AS INSTRUMENT OF PERFORMANCE-ORIENTED BUDGETING | Abstract similar documents |
| O. V. Bogacheva, V. E. Grigorov | ||
| "... and financing based on the Index are described. Conclusion. Results of application of existing evaluation ..." | ||
| Vol 15, No 3 (2022) | Funding for coronavirus health worker payments | Abstract similar documents |
| I. Yu. Bocharova, A. Yu. Rymanov | ||
| "... channel for financing COVID payments to medical workers was the allocation of transfers and subsidies ..." | ||
| Vol 14, No 4 (2021) | Economic outcomes of centralized procurements of gene therapy for patients with orphan diseases: inherited retinal dystrophy | Abstract similar documents |
| N. А. Avxentyev, Yu. V. Makarova, V. V. Kadyshev | ||
| "... of optimal way of financing gene therapy in Russia. Objective: to evaluate economic consequences ..." | ||
| Vol 11, No 4 (2018) | Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense | Abstract similar documents |
| D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy | ||
| "... Federation. We discuss the financing mechanisms of the departmental health service in the Ministry of Defense ..." | ||
| Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract similar documents |
| E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
| "... the initial volume of the financing and increase the number of patients that receive GEBD and SI due ..." | ||
| Vol 7, No 3 (2014) | THE ANALYSIS OF METHODOLOGIC CHARACTERISTICS OF RESEARCHES ON SOCIAL AND ECONOMIC BURDEN OF DISEASES IN RUSSIA IN THE FRAMES OF DEVELOPMENT OF STANDARD COST OF ILLNESS METHODOLOGY FOR THE HEALTH TECHNOLOGY ASSESSMENT | Abstract similar documents |
| V. I. Ignatyeva, M. V. Avxentyeva | ||
| "... assessment and decision making on the financing and health care management. ..." | ||
| Vol 10, No 1 (2017) | THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES | Abstract similar documents |
| N. Z. Musina, V. K. Fedyaeva | ||
| "... better decision-making on financing the medical treatment within a limited budget. With this algorithm ..." | ||
| Vol 11, No 1 (2018) | Options to optimize the access to biosimilars: analysis and solutions | Abstract similar documents |
| O. V. Kirsanova, V. V. Omelyanovsky | ||
| "... , including the growing use of costly medicines for cancer and rare (orphan) diseases. The introduction ..." | ||
| Vol 8, No 3 (2015) | GOVERNMENTAL FUNDING OF BIOMEDICAL RESEARCH IN THE UNITED STATES OF AMERICA, GREAT BRITAIN AND GERMANY | Abstract similar documents |
| G. R. Khachatrtyan, O. Yu. Rebrova, V. V. Omelyanovskiy | ||
| "... В данной публикации представлено описание международного опыта государственного финансирования ..." | ||
| Vol 12, No 3 (2019) | Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens | Abstract similar documents |
| D. V. Fedyaev , R. V. Gostishchev , V. A. Lemeshko , O. I. Ivakhnenko | ||
| "... of the extent and financing of medical care established in it, determine the level of state guarantees ..." | ||
| Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
| F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| Vol 17, No 4 (2024) | Standardized methodology for calculating the cost of medical care funded by government sources | Abstract similar documents |
| M. A. Sdvizhkova, S. A. Kovaleva, D. V. Fedyaev, V. V. Omelyanovskiy | ||
| "... источников финансирования, направленную на повышение прозрачности, стандартизацию расчетов и поддержку ..." | ||
| Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
| "... financing programs of drug supply. The initial steps in preparation for the reform of the system should ..." | ||
| Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract similar documents |
| D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
| Vol 12, No 2 (2019) | Organizational structure and funding of health technology assessment agencies around the world | Abstract similar documents |
| G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak | ||
| "... Цель - представляется актуальным изучение зарубежного опыта организации работы и финансирования ..." | ||
| Vol 13, No 2 (2020) | Affordability of in vivo gene therapy. Problems and potential solutions | Abstract similar documents |
| V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko | ||
| "... Aim. To review foreign approaches to the evaluation and financing of in vivo gene therapy drugs ..." | ||
| Vol 10, No 1 (2017) | CLINICAL AND ECONOMIC EVALUATION OF ERIBULIN EFFECTIVENESS IN SOFT TISSUE SARCOMA: RESULTS OF META-ANALYSIS | Abstract similar documents |
| P. V. Мazin, I. V. Sheshunov, N. K. Mazina, E. M. Markova | ||
| "... (STS) – rare, but severe malignancies. Aim of the study. To perform the pharmacoeconomic evaluation ..." | ||
| Vol 9, No 4 (2016) | FACTORS AND EFFECTS OF PRIVATE HEALTH SPENDING | Abstract similar documents |
| O. A. Zarubina, N. N. Sisigina | ||
| "... health financing policy, significant discretionary (breadth and depth of social healthcare system, public ..." | ||
| Vol 12, No 4 (2019) | Evolution of healthcare provider payment mechanisms | Abstract similar documents |
| V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina | ||
| "... Methods of payment to care providers constitute an essential part of the healthcare financing ..." | ||
| Vol 9, No 3 (2016) | COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE | Abstract similar documents |
| A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii | ||
| "... эффективного и справедливого финансирования здравоохранения, о которых и пойдет речь в данной статье. ..." | ||
| Vol 11, No 3 (2018) | Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review | Abstract similar documents |
| D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin | ||
| "... leukoencephalopathy. However, an additional assessment of the risk caused by rare adverse events is needed. ..." | ||
| Vol 7, No 4 (2014) | IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? | Abstract similar documents |
| V. V. Omelyanovskiy | ||
| "... анализ зарубежных систем ценообразования и государственного финансирования лекарственного ..." | ||
| Vol 12, No 1 (2019) | Individual cost accounting in the management of medical organizations | Abstract similar documents |
| I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali | ||
| "... medical insurance and rationalization of the requested financing of the medical organization depends ..." | ||
| Vol 8, No 2 (2015) | MAGNESIUM DEFICIENCY OF PATIENTS WITH HORMONE DEPENDENT DISEASES: PHARMACOEPIDEMIOLOGICAL PROFILE AND LIFE QUALITY ASSESSMENT | Abstract similar documents |
| Dmitry Vladislavovich Blinov, Juliana Vladimirovna Zimovina, Elena Anatol'evna Sandakova, Tat'yana Igorevna Ushakova | ||
| "... , нежели в гинекологии. Распространенность ДМ при гинекологических заболеваниях остается неизвестной ..." | ||
| Vol 13, No 4 (2020) | The social-economic burden of spinal muscular atrophy in Russia | Abstract similar documents |
| A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina | ||
| "... орфанных заболеваний, характеризующихся прогрессивной дегенерацией мотонейронов и потерей их функции ..." | ||
| Vol 16, No 4 (2023) | Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen | Abstract similar documents |
| I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
| "... публикаций по взаимосвязи ХС/ГС/НК-II и опухолевых заболеваний, найденных по запросу «(glucosamine OR ..." | ||
| Vol 16, No 3 (2023) | The role of ferritin in liver disease assessment | Abstract similar documents |
| V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik | ||
| "... Актуальность. Ферритин является важным интегральным и диагностическим маркером заболеваний печени ..." | ||
| Vol 9, No 4 (2016) | COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY | Abstract similar documents |
| V. S. Dombrovskiy, G. R. Khachatryan | ||
| "... инфекционных заболеваний. Рассматриваются источники финансирования таких программ и сведения об их реализации ..." | ||
| Vol 14, No 3 (2021) | Increasing the medico-economic efficiency of preventive counseling for patients with arterial hypertension and behavioral risk factors for non-communicable diseases | Abstract similar documents |
| O. L. Zadvornaya, A. N. Pishchita | ||
| "... повышение медикоэкономической эффективности профилактики сердечно-сосудистых заболеваний (ССЗ). Материал и ..." | ||
| Vol 8, No 2 (2015) | ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA | Abstract similar documents |
| Elamin H. Elbasha, Elena Aleksandrovna Pyadushkina, Maria Vladimirovna Avxentyeva, Alexander Gennadievich Tolkushin, Maxim Yurievich Frolov | ||
| "... of applicable norms of financing of the Russian Federation. Consumptions of health care resources and life ..." | ||
| 1 - 50 of 190 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
